Pre-order Enquiry
Request Free Sample
Global Nanoparticles in Biotechnology and Pharmaceuticals Market Professional Survey Report 2019
SKU ID : QYR-14649932 | Publishing Date : 05-Sep-2019 | No. of pages : 118
Request Sample
Request Customization
Check Discounts
Nanoparticles are sub-nanosized colloidal structures composed of synthetic or semi-synthetic polymers. These are used in biotechnology and pharmaceutical sectors for studying biological systems for diagnosing diseases and focusing on treatment at the molecular level. The properties of many conventional materials alter when formed from nanoparticles, the reason being nanoparticles have a greater surface area per weight than larger particles, making them more reactive to other molecules
The nanoparticle segment of the nanotechnology has wider application in pharmaceuticals such as in drug delivery and drug discovery, and in biotechnology such as in studying cellular dynamics and stem cell research. Nanotechnology is growing steadily supported by governments and technology firms making high investments in developing nanotechnology.
Sedentary lifestyles and unbalanced diets, supported by the growing rate of urbanization, are consequent in increased widespread prevalence of chronic diseases. Chronic and lifestyle diseases such as cancer, heart diseases, stroke, chronic respiratory diseases, and diabetes. Nanoparticles are utilized to determine the biological alterations of peptide and protein fragments. This diagnosis aids in developing new treatment solutions to treat the growing incidences of chronic diseases. The increasing prevalence of chronic diseases is identified to be one of the key trends having a positive impact on the nanoparticles market in biotechnology and pharmaceutical sectors.
The global Nanoparticles in Biotechnology and Pharmaceuticals market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Nanoparticles in Biotechnology and Pharmaceuticals volume and value at global level, regional level and company level. From a global perspective, this report represents overall Nanoparticles in Biotechnology and Pharmaceuticals market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Nanoparticles in Biotechnology and Pharmaceuticals in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Nanoparticles in Biotechnology and Pharmaceuticals manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Roche
GE Healthcare
Merck
Novartis
AMAG Pharmaceuticals
Amgen
Bausch & Lomb
Biogen
Celgene
Gilead
Ipsen
Leadiant Biosciences
nanoComposix
Pacira Pharmaceuticals
Pfizer
Shire
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Fullerenes
Liquid Crystals
Liposomes
Nanoshells
Quantum dots
Superparamagnetic nanoparticles
Segment by Application
Biotechnology
Pharmaceutical
The nanoparticle segment of the nanotechnology has wider application in pharmaceuticals such as in drug delivery and drug discovery, and in biotechnology such as in studying cellular dynamics and stem cell research. Nanotechnology is growing steadily supported by governments and technology firms making high investments in developing nanotechnology.
Sedentary lifestyles and unbalanced diets, supported by the growing rate of urbanization, are consequent in increased widespread prevalence of chronic diseases. Chronic and lifestyle diseases such as cancer, heart diseases, stroke, chronic respiratory diseases, and diabetes. Nanoparticles are utilized to determine the biological alterations of peptide and protein fragments. This diagnosis aids in developing new treatment solutions to treat the growing incidences of chronic diseases. The increasing prevalence of chronic diseases is identified to be one of the key trends having a positive impact on the nanoparticles market in biotechnology and pharmaceutical sectors.
The global Nanoparticles in Biotechnology and Pharmaceuticals market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Nanoparticles in Biotechnology and Pharmaceuticals volume and value at global level, regional level and company level. From a global perspective, this report represents overall Nanoparticles in Biotechnology and Pharmaceuticals market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Nanoparticles in Biotechnology and Pharmaceuticals in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Nanoparticles in Biotechnology and Pharmaceuticals manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Roche
GE Healthcare
Merck
Novartis
AMAG Pharmaceuticals
Amgen
Bausch & Lomb
Biogen
Celgene
Gilead
Ipsen
Leadiant Biosciences
nanoComposix
Pacira Pharmaceuticals
Pfizer
Shire
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Fullerenes
Liquid Crystals
Liposomes
Nanoshells
Quantum dots
Superparamagnetic nanoparticles
Segment by Application
Biotechnology
Pharmaceutical
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
